Medical research

Experimental brain cancer drug fast tracked in clinical trials

An experimental drug being trialed for advanced solid tumors, including the most aggressive brain cancer—glioblastoma—has passed the first phase with flying colors, raising hopes for an effective new treatment.

Oncology & Cancer

New clinical guideline on radiation therapy for IDH-mutant glioma

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides recommendations on the use of radiation therapy to treat patients with isocitrate dehydrogenase (IDH)-mutant grade 2 and grade 3 diffuse ...

page 8 from 38